|
Post by prcgorman2 on Jan 19, 2024 8:37:42 GMT -5
That's a good VDEX commercial. Simple, to the point, and effective in my opinion. If there was an ad agency or advisor for this item, Mike might consider engaging them because hamburgers on a hook was dumb; again, in my opinion. You've got to have flying hamburgers or people dancing around a fountain to give time for the FDA disclaimer voice overs to be done. Take your pick, but due to FDA requirements most drug commercials are pretty lame. Of course it helps if a drug has some metric of superiority proven to the FDA's satisfaction and thus allowed mention in the commercial, which of course we know Afrezza does not. If you dig around you can find quite a bit of reading material on FDA “guidelines” for advertising. It is depressing. Years ago I described a commercial where two persons with diabetes get together for lunch. One retires to the restroom to administer RAA to their abdomen, the other studies the menu. They order. The RAA frets over the slow service as their BG numbers drop on ther CGM. Food arrives. Low carb on RAA, high carb on Afrezza side. After eating CGM numbers are compared over time. I’m not sure I suggested CGMs the first time I described this idea, but it would help illustrate the time action of Afrezza as compared to RAA. I doubt we’ll ever see a commercial like that, but it’s the same basic idea that MannKind will try to demonstrate with studies. Afrezza is ultra-rapid just like human insulin because it is human insulin in an immediately bio-available form. The product is awesome. But there is all this other stuff to contend with.
|
|
|
Post by agedhippie on Jan 19, 2024 10:06:14 GMT -5
You've got to have flying hamburgers or people dancing around a fountain to give time for the FDA disclaimer voice overs to be done. Take your pick, but due to FDA requirements most drug commercials are pretty lame. Of course it helps if a drug has some metric of superiority proven to the FDA's satisfaction and thus allowed mention in the commercial, which of course we know Afrezza does not. If you dig around you can find quite a bit of reading material on FDA “guidelines” for advertising. It is depressing. Years ago I described a commercial where two persons with diabetes get together for lunch. One retires to the restroom to administer RAA to their abdomen, the other studies the menu. They order. The RAA frets over the slow service as their BG numbers drop on ther CGM. Food arrives. Low carb on RAA, high carb on Afrezza side. After eating CGM numbers are compared over time. I’m not sure I suggested CGMs the first time I described this idea, but it would help illustrate the time action of Afrezza as compared to RAA. I doubt we’ll ever see a commercial like that, but it’s the same basic idea that MannKind will try to demonstrate with studies. Afrezza is ultra-rapid just like human insulin because it is human insulin in an immediately bio-available form. The product is awesome. But there is all this other stuff to contend with. This suffers from the same problem as the ice cream advert - it's not going to resonate with most diabetics because it's not realistic. People don't retire to the restroom to dose (well, not after the first year ), they just inject. If people don't like it that's their problem, the only down side is that it leads to questions and people telling you how to treat your diabetes. These days though you use an app on your phone and the pump does the rest. Likewise fretting over slow delivery - that's a bonus since you have now prebolused so your numbers will be better (usually you just dose when the food arrives.) As for carbs, I eat whatever I want and take insulin to cover. The CGM part is the only part that is possibly valid, but most diabetics I know are more concerned about total TIR rather than a point in time.
|
|
|
Post by akemp3000 on Jan 19, 2024 10:27:03 GMT -5
I'm asking only because I truly don't know. Do diabetics really inject in their abdomen or elsewhere while sitting at a nice restaurant table? And do they really consider an objection to this the problem of the other restaurant patrons?
|
|
|
Post by agedhippie on Jan 19, 2024 11:01:24 GMT -5
I'm asking only because I truly don't know. Do diabetics really inject in their abdomen or elsewhere while sitting at a nice restaurant table? And do they really consider an objection to this the problem of the other restaurant patrons? Yes to both of those (although maybe the people in support groups are more assertive.). To be fair you don't make a huge production of it and usually people never even notice it happened. These days it's largely pumps rather than injections and those use apps on your phone.
|
|
|
Post by prcgorman2 on Jan 19, 2024 11:57:23 GMT -5
If you dig around you can find quite a bit of reading material on FDA “guidelines” for advertising. It is depressing. Years ago I described a commercial where two persons with diabetes get together for lunch. One retires to the restroom to administer RAA to their abdomen, the other studies the menu. They order. The RAA frets over the slow service as their BG numbers drop on ther CGM. Food arrives. Low carb on RAA, high carb on Afrezza side. After eating CGM numbers are compared over time. I’m not sure I suggested CGMs the first time I described this idea, but it would help illustrate the time action of Afrezza as compared to RAA. I doubt we’ll ever see a commercial like that, but it’s the same basic idea that MannKind will try to demonstrate with studies. Afrezza is ultra-rapid just like human insulin because it is human insulin in an immediately bio-available form. The product is awesome. But there is all this other stuff to contend with. This suffers from the same problem as the ice cream advert - it's not going to resonate with most diabetics because it's not realistic. People don't retire to the restroom to dose (well, not after the first year ), they just inject. If people don't like it that's their problem, the only down side is that it leads to questions and people telling you how to treat your diabetes. These days though you use an app on your phone and the pump does the rest. Likewise fretting over slow delivery - that's a bonus since you have now prebolused so your numbers will be better (usually you just dose when the food arrives.) As for carbs, I eat whatever I want and take insulin to cover. The CGM part is the only part that is possibly valid, but most diabetics I know are more concerned about total TIR rather than a point in time. I like your input but I’ve had different experience with friends who were T1 and T2 in terms of going to the bathroom to inject before a meal at restaurants (and bars). That was some time ago so perhaps they’re using pumps now. Regardless, your comments are well taken.
|
|
|
Post by porkini on Jan 19, 2024 20:16:08 GMT -5
I'm asking only because I truly don't know. Do diabetics really inject in their abdomen or elsewhere while sitting at a nice restaurant table? And do they really consider an objection to this the problem of the other restaurant patrons? To me, it seems like older PWDs are more private about their treatment unless questioned directly. On the other hand, our one good friend with diabetes is quite open about the disease. Not pushy though, only if others want or need to know. When out to eat, she always asks those around her if there are issues with her injecting at the table (never been any when we've been out with her). She is so practiced at administering her injections that if you are not looking at her the entire time, you might well miss when she injects, it is so quick and efficient.
|
|